ConductScience.org, home

Gene · 92521

Papers3,158

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

681 to 700 of 3,158

Download this page as JSON
TitleJournalYearPMIDFound bySource
Severe acute respiratory disease in American mink experimentally infected with SARS-CoV-2.JCI Insight202236509288PubTator, text miningPubMed
Green and Regioselective Approach for the Synthesis of 3-Substituted Indole Based 1,2-Dihydropyridine and Azaxanthone Derivatives as a Potential Lead for SARS-CoV-2 and Delta Plus Mutant Virus: DFT and Docking Studies.
ACS Omega202236506171PubTator, text miningPubMed
Insights into the Dynamics and Binding of Two Polyprotein Substrate Cleavage Points in the Context of the SARS-CoV-2 Main and Papain-like Proteases.Molecules202236500348PubTator, text miningPubMed
Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology.Molecules202236500347PubTator, text miningPubMed
Focus on Marine Animal Safety and Marine Bioresources in Response to the SARS-CoV-2 Crisis.Int J Mol Sci202236499463PubTator, text miningPubMed
Computational Study of Helicase from SARS-CoV-2 in RNA-Free and Engaged Form.Int J Mol Sci202236499049PubTator, text miningPubMed
Prediction of Recurrent Mutations in SARS-CoV-2 Using Artificial Neural Networks.Int J Mol Sci202236499005PubTator, text miningPubMed
Biochemical and structural insights into SARS-CoV-2 polyprotein processing by Mpro.Sci Adv202236490335PubTator, text miningPubMed
Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteins.Front Microbiol202236478862PubTator, text miningPubMed
Distribution of intra-host variations and mutations in the genomes of SARS-CoV-2 and their implications on detection and therapeutics.MedComm (2020)202236474856PubTator, text miningPubMed
Prevalence and genomic characterization of rotavirus group A genotypes in piglets from southern highlands and eastern Tanzania.Heliyon202236468104PubTator, text miningPubMed
Structural differences in 3C-like protease (Mpro) from SARS-CoV and SARS-CoV-2: molecular insights revealed by Molecular Dynamics Simulations.Struct Chem202236467259PubTator, text miningPubMed
Insights into the structural properties of SARS-CoV-2 main protease.Curr Res Struct Biol202236466947PubTator, text miningPubMed
Small molecules in the treatment of COVID-19.Signal Transduct Target Ther202236464706PubTator, text miningPubMed
Viral proteases as therapeutic targets.Mol Aspects Med202236459838PubTator, text miningPubMed
In silico evaluation of flavonoids as potential inhibitors of SARS-CoV-2 main nonstructural proteins (Nsps)-amentoflavone as a multitarget candidate.J Mol Model202236445575PubTator, text miningPubMed
Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection.Front Pharmacol202236438815PubTator, text miningPubMed
Ferulic acid derivatives block coronaviruses HCoV-229E and SARS-CoV-2 replication in vitro.Sci Rep202236434137PubTator, text miningPubMed
Computational investigation of natural compounds as potential main protease (Mpro) inhibitors for SARS-CoV-2 virus.Comput Biol Med202236423529PubTator, text miningPubMed
Zoonotic RVA: State of the Art and Distribution in the Animal World.Viruses202236423163PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/92521/papers?page=35